Listed

Outset Medical, Inc.: Form 10-Q for the period ended Sep 30, 2020

Filed with the SEC on Nov 12, 2020 and accepted by EDGAR at Nov 12, 2020, 08:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-07-01 to 2020-09-30$13.8mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2020-01-01 to 2020-09-30$32.7mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-07-01 to 2020-09-30$18.9mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2020-01-01 to 2020-09-30$46.1mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2020-07-01 to 2020-09-30−$5.1mus-gaap:GrossProfit
Gross profit9 months2020-01-01 to 2020-09-30−$13.5mus-gaap:GrossProfit
Research and development3 months2020-07-01 to 2020-09-30$9.2mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2020-01-01 to 2020-09-30$21.1mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2020-07-01 to 2020-09-30−$40.7mus-gaap:OperatingIncomeLoss
Operating income9 months2020-01-01 to 2020-09-30−$85.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-07-01 to 2020-09-30$428.0kus-gaap:InterestExpense
Interest expense9 months2020-01-01 to 2020-09-30$2.5mus-gaap:InterestExpense
Net income3 months2020-07-01 to 2020-09-30−$42.3mus-gaap:NetIncomeLoss
Net income9 months2020-01-01 to 2020-09-30−$89.4mus-gaap:NetIncomeLoss
Diluted EPS9 months2020-01-01 to 2020-09-30−$6.30us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2020-01-01 to 2020-09-30−$73.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2020-01-01 to 2020-09-30$6.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-09-30$311.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-09-30$367.8mus-gaap:AssetsCurrent
Total assetsAt period end2020-09-30$426.0mus-gaap:Assets
Current liabilitiesAt period end2020-09-30$33.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-09-30$71.7mus-gaap:Liabilities
Long-term debtAt period end2020-09-30$29.7mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2020-09-30$354.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-20-053315. Last ingested by Listed: Nov 14, 2026, 11:29 ET. Listed shows no prices and gives no investment advice.